A novel anti-c-Kit antibody-drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumors

Kim, JO; Kim, KH; Baek, EJ; Park, B; So, MK; Ko, BJ; Ko, HJ; Park, SG

Park, SG (通讯作者),Ajou Univ, Coll Pharm, 206 World Cup Ro, Suwon 16499, Gyeonggi Do, South Korea.

MOLECULAR ONCOLOGY, 2022; 16 (6): 1290

Abstract

c-Kit overexpression and activating mutations, which are reported in various cancers, including gastrointestinal stromal tumor (GIST), small-cell lung......

Full Text Link